BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Ultragenyx Pharmaceuticals 

77 Digital Drive
Suite 210
Novato  California  94949  U.S.A.
Phone: 415-884-0223 Fax: 415-884-0562


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Ultragenyx Pharmaceuticals (RARE) Announces Initiation Of Phase 3 Study Of Recombinant Human Beta-Glucuronidase In Mucopolysaccharidosis Type 7 12/15/2014 7:29:24 AM
Ultragenyx Pharmaceuticals (RARE) To Present At The Oppenheimer Healthcare Conference 12/5/2014 10:58:56 AM
Ultragenyx Pharmaceuticals (RARE) Reports Third Quarter 2014 Financial Results And Corporate Update 11/10/2014 8:03:11 AM
Ultragenyx Pharmaceuticals (RARE) To Present At The Credit Suisse Annual Healthcare Conference 11/4/2014 10:08:43 AM
Ultragenyx Pharmaceuticals (RARE) Granted EU Orphan Drug Designation For KRN23 For The Treatment Of X-Linked Hypophosphatemia 10/30/2014 7:54:56 AM
Ultragenyx Pharmaceuticals (RARE) Granted Orphan Drug Designation For Triheptanoin For The Treatment Of Glucose Transporter Type-1 Deficiency Syndrome 10/27/2014 7:54:46 AM
Ultragenyx Pharmaceuticals (RARE) Announces Interim Data From Phase 2 Extension Study Of Sialic Acid Extended-Release At International Congress Of The World Muscle Society 10/13/2014 8:15:40 AM
Ultragenyx Pharmaceuticals (RARE) To Present At The Leerink Partners Rare Disease Roundtable 9/24/2014 7:48:58 AM
Ultragenyx Pharmaceuticals (RARE) Announces Positive Results From A Long-Term Phase 1/2 Study Of KRN23 In Adult Patients With X-Linked Hypophosphatemia 9/15/2014 8:12:15 AM
Ultragenyx Pharmaceuticals (RARE) To Present At The Morgan Stanley (MST) Global Healthcare Conference 9/4/2014 10:21:59 AM
12345678